F Meyer, É Chen, N Berrogain, P O Bosset, S Campagne-Loiseau, V Cardot, T Charles, X Deffieux, L Donon, L Even, F Girard, J-F Hermieu, S Hurel, J Klap, L Peyrat, C Thuillier, B Tibi, A Vidart, L Wagner, J-N Cornu
INTRODUCTION: Inflammatory and sensory chronic bladder diseases have a significant impact on quality of life. These pathologies share alteration of the layer between urine and urothelium, making the use of topical agents appropriate. OBJECTIVES: Review the efficacy and tolerance of intravesical treatments for these pathologies. Give practical guidelines for the use of agents currently available in France. METHOD: A narrative review was performed in March 2021 using PubMed/MEDLINE, Google Scholar and the international guidelines...
April 2022: Progrès en Urologie